While methylated ZNF154 fragments were also detected in the healthy controls, these levels were sufficiently low, enabling us to maintain high specificity, which is also consistent with the observation that ZNF154 hypermethylation is an early event in cancers, including pancreatic cancer, and is also absent in noncancer conditions, as we show in this study. The gene discussed is ZNF154; the disease is cancer.